News
My Top 10 Personal Holdings Many readers have expressed interest in my personal investments, and I think it is important to be as transparent...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
News
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
News
This article was written by Follow Richard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the...
News
This article is reprinted by permission from NerdWallet. It’s the summer of Barbie. The movie release date is set for July 21, but the...
News
When it comes to investment returns, real estate has historically been a great option. Many people have achieved great wealth by investing in real...
News
Where are you headed this summer? Everyone knows all the usual vacation hot spots, the popular go-to locales — wonderful places, sure, but too...
News
In this article, I will outline why I think T. Rowe Price Group, Inc. (NASDAQ:TROW) is a buy at this time. I will explain...
News
Introduction According to the 2022 10K, ExlService Holdings (NASDAQ:EXLS), is a leading data analytics and digital operations and solutions company that partners with clients...
News
Lucid Group (NASDAQ:LCID) is full of risks. In times of uncertain macroeconomic conditions and a high-interest rate environment, the company is immensely unprofitable. In...
News
Introduction Reneo Pharmaceuticals (NASDAQ:RPHM) is a clinical-stage company developing therapies for rare genetic mitochondrial diseases, characterized by impaired mitochondrial ATP production. The company’s primary...
News
Introduction Puma Biotechnology (NASDAQ:PBYI) is a biopharmaceutical firm focused on enhancing cancer care through innovative solutions. The company is recognized for the commercialization of...
News
JPMorgan Chase & Co. (NYSE:JPM) turned in a spectacular second-quarter earnings report for the year 2023! Grab these numbers and think about them for...
